The People Behind Strata

Founded by clinicians, clinical investigators, and research scientists, Strata brings together the experts who helped shape psychedelic treatment delivery within leading FDA-regulated clinical trials. Our team combines deep clinical experience with a commitment to rigorous, evidence-based training and care.

Founders

Mark Steven Burton, PhD

Chief Executive Officer (CEO)

Stephanie Knatz Peck, PhD

Chief Clinical Officer (CCO)

Carolina Maggio, MBACP

Vice President of Training

Business Operations

Joy Sun Cooper, MBA

Chief Business Officer (CBO)

Jamie Berlick, MA

Jamie Berlick, MA

Lead Operations Coordinator

Technology

Greg Ryslik, PhD

Greg Ryslik, PhD

Executive Technology Lead

Bob Dougherty, PhD

Bob Dougherty, PhD

AI Systems & Infrastructure

Jacob Birk

Jacob Birk

Lead Engineer

Advisors

Ekaterina Malievskaia, MD

Ekaterina Malievskaia, MD

Senior Advisor

Boadie Dunlop, MD

Boadie Dunlop, MD

Scientific & Medical Advisory Board

Sid Sizook, MD

Sid Sizook, MD

Scientific & Medical Advisory Board

Marco Mohwinckel

Marco Mohwinckel

Commercial Advisory Board

Gino Martocci

Gino Martocci

Commercial Advisory Board

Scott Aaronson, MD

Scott Aaronson, MD

Scientific & Medical Advisory Board

Training Faculty

Jess Maples-Keller, PhD

Marc Axiala, MS

Brooke Balliet, LMFT

Susan Wait, MD

Steve Thayer, PhD

Julie Kawasaki

Sabina Pillai, MA

Sabina Pillai, MA

Amy Durden, MA

Liz Lilley

Joseph Cattel

Patricia Pop, MD

Katherine Eisen, PhD

Safarzadeh Kousha, MSc

Lauren Milburn

Lauren Milburn

Zak Kelm, DO

Thomas Meyer, PhD

Thomas Meyer, PhD

Łukasz Warchoł

Bethany Mealy, MA

Katja Cahoon

Rachel Cooksey

Mary Burns, MD

Mary Burns, MD

Jan Mars

Julie Trim, PhD

Tom Sharp